From there, your provider builds a plan around your health, your goals, and how the medication is likely to fit into daily life
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to diet and physical activity
However, patients should carefully evaluate the credibility of the provider, pharmacy transparency, and medical oversight involved
Possession or use of investigational drugs outside an authorized clinical trial may be illegal in your jurisdiction
Tirzepatide is often used as part of a comprehensive, long-term weight management strategy that includes ongoing physician supervision, healthy lifestyle habits, and regular progress evaluations to help maintain results